Merrimack Pharmaceuticals
MACK
#7821
Rank
NZ$0.38 B
Marketcap
$25.79
Share price
0.00%
Change (1 day)
21.97%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.18

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.19 an increase over its 2021 EPS that were of -$0.31.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.18-3.54%
2022-$0.19-38.89%
2021-$0.31-25%
2020-$0.41-81.54%
2019-$2.22-56.95%
2018-$5.15-108.5%
2017$60.52-390.35%
2016-$20.84-7.35%
2015-$22.5065%
2014-$13.64-39.39%
2013-$22.50-54.01%
2012-$48.92-53.71%
2011-$105.6840.37%
2010-$75.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.42-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.43 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.58 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.22 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.61 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA